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 ABSTRACT 
Mammalian DNA methyltransferase 1 (DNMT1) is essential during early embryo 
development. Consistent with its key role in embryogenesis, depletion of this 
protein in adult somatic cells promotes severe cellular dysfunctions and cell 
death. DNMT1 contains a highly evolutionary conserved C-terminal catalytic 
DNA methyltransferase domain that is thought to be the responsible for the 
maintenance of CpG methylation patterns in the genome. DNMT1 has also a 
large N-terminal region with different functional protein-protein and protein-DNA 
binding domains. The multi-domain N-terminal region and the abundant 
molecular binding patterns suggest potential non-catalytic functions for DNMT1. 
However, this hypothesis remains controversial and conflicting results can be 
found in the literature. Here, recent results presenting a functional role for 
DNMT1 independent of its catalytic domain are discussed. 
 
 Methylation of the C-5´ position of cytosine (5mC) is a major epigenetic 
landmark of the DNA molecule that can be found in all vertebrates and flowering 
plants, in many bacterial species and in some invertebrates, fungi and protists 
(Goll and Bestor, 2005). As a rule, genomes of higher eukaryotes present 
extensive methylation at CpG dinucleotides and a global GC content that is 
lower than expected as a result of the cytosine to thymine transition mutations 
induced by cytosine methylation. Exceptions to this general rule are short 
stretches of DNA showing a high content of non-methylated CpG nucleotides, 
known as CpG islands. CpG islands serve as essential genomic regulatory 
elements for the transcriptional activity of a large proportion of annotated genes 
and non-coding RNAs (Deaton and Bird, 2011). 
 
In higher eukaryotes, it is thought that methylation of CpG dinucleotides is 
intimately related in two ways to the regulation of transcription and, hence, to 
the configuration of particular outputs of cellular activity. At the chromatin fibre 
level, methylation of cytosine at CpG islands in promoter regions has been 
associated to a direct inhibition of the transcriptional machinery binding at 
transcription start sites and to a recruitment of 5mC-recognising transcriptional 
repressor complexes at these sites (Deaton and Bird, 2011). Cytosine 
methylation has a well-known key role in the transcriptional silencing of 
imprinted genes (Deaton and Bird, 2011; Goll and Bestor, 2005). However, it is 
worth to note that transcriptional silencing during normal development 
associated to CpG methylation of CpG island-containing promoters has been 
demonstrated for only a scarce number of non-imprinted genes (Deaton and 
Bird, 2011; Goll and Bestor, 2005). On the other hand, at a large scale genomic 
organization level, three-dimensional positioning in the nuclear compartment is 
globally associated to transcriptional activity (Fraser and Bickmore, 2007; 
Misteli, 2007). In this context, it is becoming clear that the extensive CpG 
methylation patterns of large genomic regions, mostly repetitive elements such 
as SINE, LINE and satellite families, which embrace the most part of 5mC in the 
genome of higher eukaryotes, can have a significant role in the positioning 
process of chromosome territories and nuclear components in the nuclear 
compartment (Espada and Esteller, 2009).  
 Despite the reported implication of CpG methylation in the regulation of gene 
expression, the precise role of this biochemical process during embryo 
development and in the regulation of cell function in adult tissues is not clear. 
As mentioned above, with the exception of imprinted genes, only a few genes 
containing CpG islands in the promoter region are silenced by CpG methylation. 
For many of these genes, active transcriptional silencing precedes cytosine 
methylation, suggesting that methylation acts as a mechanism to maintain 
silenced genes in a stable and heritable repressed state rather than a 
mechanism for a dynamic regulation of gene expression. On the other hand, 
organisms showing extensive genomic DNA methylation and organisms having 
little or no 5mC share conserved molecular signalling circuits that have key 
roles during development (Goll and Bestor, 2005). This fact suggests that the 
biochemical methylation of cytosine is not an essential process during the 
development of pluricellular organisms. However, it has been reported that 
extensive loss of genomic CpG methylation results in cell death during 
mammalian embryo development and in mammalian adult somatic cells (Chen 
et al., 2007; Egger et al., 2006; Li et al., 1992; Spada et al., 2007). These 
observations indicate that, at least in some organism, a correct pattern of 
genomic CpG methylation is required for cell function. 
 
The establishment of the novo CpG methylation patterns in the DNA, as well as 
the maintenance of these patterns through successive DNA replication rounds, 
is catalyzed by the DNA methyltransferases (DNMT) protein family. In 
mammals, three types of DNMTs have been identified so far, namely DNMT1, 
DNMT2 and DNMT3 (including DNMT3A, DNMT3B and DNMT3L 
forms)(Bestor, 2000; Goll and Bestor, 2005; Jurkowska et al., 2011). All these 
types share 10 conserved sequence motifs that configure a defined catalytic 
domain which is highly homologous to equivalent domains in different species, 
ranging from higher eukaryotes to bacteria. Indeed, this catalytic domain points 
a basic canonical sequence that serves to define this protein family (Goll and 
Bestor, 2005). Interestingly, genetic evidence indicates that the canonical 
DNMT catalytic domain has evolved from a bacterial DNA metyltransferase 
belonging to the type II restriction-modifications systems. These bacterial 
systems confer resistance to viral infections but are not implicated in the 
regulation of gene expression (Goll and Bestor, 2005). 
 
Mammalian DNMT1 was the first identified and the most abundant DNMT type 
in mammalian somatic cells (Bestor, 2000; Goll and Bestor, 2005). This enzyme 
is present at functional replication foci, showing a strong preference for 
hemymethylated DNA, and is, therefore, considered as the protein responsible 
for the maintenance of global methylation patterns in the genome. Mammalian 
DNMT1 shows a conserved C-terminal catalytic domain and a large N-terminal 
domain that contains different regulatory motifs, including DMAP1 and PCNA 
interaction domains, a replication foci-targeting domain, a KEN box/Zn finger 
domain and two bromo-adjacent homology (BAH) domains (Fig. 1A) (Jurkowska 
et al., 2011). The abundance of protein-protein and protein-DNA binding 
domains in the N-terminal region of DNMT1 indicates that this protein is 
potentially involved in a complex network of regulatory circuits in the cell 
nucleus, a fact that has been confirmed by different reports in the last years 
(Jurkowska et al., 2011). 
 
The functional relevance of DNMT1 during mammalian embryo development 
and in the homeostasis of adult tissues is highlighted by genetic experiments in 
mouse models and human somatic cells. Deletion of both Dnmt1 alleles in the 
mouse results in embryonic lethality by day 8.5 post coitum (Li et al., 1992). 
Embryos showed an almost complete (up 95%) demethylation of the DNA 
molecule. Notably, this rate of DNA demethylation has no apparent effect on 
cell viability from day 0 to day 8.5 post coitum, during witch time two sequential 
waves of complete demethylation and “de novo” methylation take place in the 
genome of the developing embryo. In line with this, mouse ES cells maintained 
in an undifferentiated state can survive to an almost complete CpG 
demethylation of the DNA molecule, but induction of a differentiation program in 
these demethylated ES cells rapidly results in cell death (Li et al., 1992). In a 
similar way, reduction of DNMT1 expression below a critical 20% threshold in 
human somatic (differentiated) cells results in extensive CpG demethylation, 
loss of cell viability and cell death after mitotic catastrophe (Chen et al., 2007; 
Egger et al., 2006; Spada et al., 2007). Equally important, a causal link between 
DNMT1 mutations and human hereditary disease, namely a sensory 
neuropathy, has been recently  reported (Klein et al., 2011). 
 
The existence of functional roles for DNMT1 independent of its catalytic activity 
is a suggestive and plausible hypothesis when considering its large N-terminal 
domain and the plethora of molecular binding patterns attributed to this protein. 
However, no clear evidence to sustain such hypothesis has been reported to 
date and the matter has remained controversial in the literature. For example, it 
has been shown that depletion of mammalian DNMT1 can result in activation of 
gene transcription by a DNA methylation- independent mechanism (Milutinovic 
et al., 2004). In a similar way, it has been reported an essential gene silencing 
activity for xDnmt1 during early Xenopus leavis embryo development that is 
independent of its catalytic activity (Dunican et al., 2008). By contrast, it has 
also been claimed that a catalytic DNA methyltransferase activity is required for 
all biological functions of DNMT1 (Damelin and Bestor, 2007). In this context, it 
is to note that the ideal experimental framework to analyze potential non-
catalytic functions of DNMT1 (and, by extension, of any other enzyme) is to 
introduce a catalytically inactive form of the enzyme in a defined cellular 
background. The complete elimination of the endogenous full-length enzyme is 
formally required in this experimental context, since all the non-catalytic 
domains of the endogenous protein can unmask the effects of the non-catalytic 
domains of the exogenous mutant protein. As mentioned above, a complete 
deletion of DNMT1 in committed mammalian cells results in cell death and, 
therefore, this experimental approach is not suitable to analyze non-catalytic 
functions of this protein. Different experimental designs and model systems are 
then required to elucidate non-catalytic functions of DNMT1. 
 
In a recent report, an alternative experimental approach has been used to 
demonstrate that human DNMT1 can have biological functions that are 
independent of its DNA methyltransferase activity (Espada et al., 2011). In 
particular, it has been shown that the DMAP1/PCNA domains in the N-terminal 
region of DNMT1 are implicated in the transcriptional regulation of E-cadherin. 
Interestingly, the regulation of E-cadherin expression that occurs in this context 
is associated to a modulation of β-catenin signalling and can induce an 
epithelial-to-mesenchymal transition. In this study, human cancer cells 
expressing low levels of a DNMT1 hypomorph that lacks exons 3-6 (DNMT1∆E3-
6) are used as experimental model system (Fig. 1A) (Egger et al., 2006; Rhee et 
al., 2000; Spada et al., 2007). This DNMT1 hypomorph can sustain a moderate 
catalytic activity that seems to be sufficient to maintain cell viability. However, 
DNMT1∆E3-6 expressing cells present an extensive and selective CpG 
demethylation at repetitive pericentromeric elements (Espada et al., 2004). 
Interestingly, this selective DNA demethylation pattern is associated to a shift in 
the histone H3 biochemical modification pattern in those regions and to an 
overall alteration of heterochromatin organization that results in an aberrant 
nuclear morphology (Espada et al., 2004). Demethylation of repetitive rRNA 
genes and a functional disorganization of the nucleolar compartment is also 
observed in DNMT1∆E3-6 expressing cells (Espada et al., 2007). 
 
In the referred report it is shown that, while parental cells present well formed E-
cadherin-dependent cell-cell contacts, DNMT1∆E3-6 expressing cells show a 
significant down regulation of the E-cadherin gene at the transcriptional level. 
This down regulation of E-cadherin results in a disorganization of Ca2+-
dependent cell-cell contacts, release of β-catenin from adherent junctions at the 
cell membrane, translocation of β-catenin to the cell nucleus and subsequent 
activation of Wnt transcriptional targets (Espada et al., 2011). This novel 
regulatory mechanism of E-cadherin expression strictly depends on the E-
cadherin transcriptional repressor SNAIL1 and requires the interaction of this 
repressor with the DMAP1/PCNA domains of DNMT1. However, the 
mechanism is not associated to CpG methylation changes in either the E-
cadherin or SNAIL1 promoters, which are otherwise completely demethylated in 
this cellular system (Espada et al., 2011). As the sole reported difference in the 
genetic background of DNMT1∆E3-6 expressing cells with respect to parental cell 
is the deletion of exons 3-6 in the DNMT1 gene, it is concluded that this region, 
encompassing the DMAP1 and PCNA domains, but not the catalytic domain, is 
the responsible for the regulation of E-cadherin expression in DNMT1∆E3-6 
expressing cells. 
 
Associated to the DMAP1/PCNA domains deletion in the N-terminal region of 
DNMT1, SNAIL1 binding to the E-cadherin promoter is strongly induced in 
DNMT1∆E3-6 expressing cells as compared to parental cells (Espada et al., 
2011). It has also been previously reported that SNAIL1 can interact with and 
recruit the histone deacetylase modifier HDAC1 to the E-cadherin promoter to 
exert its repressor activity (Peinado et al., 2004). In agreement with this 
observation, DNMT1∆E3-6 expressing cells also shown a specific recruitment of 
HDAC1 to the E-cadherin promoter (Espada et al., 2011). On the other side, it 
was shown that a direct interaction can take place between the DMAP1/PCNA 
domain of DNMT1 and the SNAG domain of SNAIL1 (Espada et al., 2011). 
Taken into account these results, it can be hypothesized that the DMAP1/PCNA 
domain of DNMT1 can act as a binding domain to sequester the repressor 
SNAIL1/HDAC1 complex, thus preventing its interaction with the E-cadherin 
promoter (Fig 1B). An alternative splicing in the N-terminal region of DNMT1, 
deleting exons 2-6 but preserving the catalytic domain, can release the 
SNAIL1/HDAC1 repressor complex facilitating its interaction with the E-cadherin 
promoter (Fig. 1B).  The presence of the C-.terminal catalytic domain in the N-
terminal spliced DNMT1 isoform assures the maintenance of essential CpG 
methylation patterns in DNMT1∆E3-6 expressing cells, preventing the induction of 
cell death (Fig. 1B). At the same time, the differential expression of this 
DNMT1∆E3-6 isoform can promote an epithelial-to-mesenchymal transition after 
an efficient E-cadherin gene transcriptional shut-down (Fig. 1B). Complete 
deletion of full-length DNMT1 can also result in the release of the 
SNAIL1/HDAC1 repressor complex, but the absence of a functional catalytic 
domain can compromise the maintenance of DNA methylation patterns 
promoting cell death (Fig. 1B 
 
The N-terminal region of mammalian DNMT1 encompassing DMAP1 and PCNA 
domains has been implicated in specific recognition of AT-rich regions and 
localization on Line-1 and satellite repeats (Araujo et al., 2001; Suetake et al., 
2006). In the mouse, alternative splicing affecting the first N-terminal exons of 
the Dnmt1 gene is a common phenomenon during oogenesis (Mertineit et al., 
1998), muscle differentiation (Aguirre-Arteta et al., 2000) and in different 
germinal and somatic tissues (Gaudet et al., 1998; Lin et al., 2000; Sakai et al., 
2001). Differential splicing affecting the first N-terminal region of DNMT1 has 
been also reported in human cells and tissues (Bonfils et al., 2000; Hsu et al., 
1999). These observations indicate that this region is especially prone to 
genetic regulation by alternative splicing. In this context, it is tempting to 
speculate that mammalian cells can use the differential splicing of the N-
terminal region of DNMT1 as a common mechanism to regulate DNMT1 
localization and function.  This is a novel concept that has been reinforced by 
the experimental use of human cells genetically manipulated to force the 
expression of a DNMT1 isoform lacking a competent DMAP1/PCNA region but 
having a functional catalytic domain.  As a whole, the observations discussed 
here suggest that the existence of biologically significant functions of DNMT1 
that are independent of its catalytic activity is a plausible hypothesis. Further 
experiments are required to probe this hypothesis in “in vivo” systems.  
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 FIGURE LEGEND 
 
Figure 1. Non-catalytic functions of DNMT1. A) Schematic representation of 
the DNMT1 full-length protein and of a DNMT1 isoform resulting from a 
differential splicing of exons 3 to 6, encompassing the DMAP1 and PCNA 
domains. The extension and localization of the different structural domains of 
DNMT1 are indicated. Representations are not drawn to scale. B) Hypothetical 
model depicting a potential non-catalytic function of DNMT1 that is implicated in 
the regulation of E-cadherin expression. The DMAP1 and PCNA domains in the 
N-terminal region of DNMT1 can interact with SNAIL1/HDAC1 repressor 
complex, impeding the interaction of this repressor complex with the E-cadherin 
promoter (upper panels).  An alternative splicing deleting the DMAP1 and 
PCNA domains of DNMT1 promotes the release of the SNAIL1/HDAC1 
complex that can then interact with and repress the activity of the E-cadherin 
promoter; down regulation of E-cadherin expression can promote an epithelial-
to-mesenchymal transition (EMT) (middle panels). The presence of a fully active 
catalytic domain in this DNMT1 isoform assures the maintenance of DNA 
methylation patterns through successive DNA replication rounds, preventing cell 
death. However, full length deletion of DNMT1 can release SNAIL1/HDAC1 
repressor complexes but also promotes an extensive demethylation of the DNA 
that ultimately results in cell death (lower panels).  
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